Literature DB >> 26827600

High-Performance Affinity Chromatography: Applications in Drug-Protein Binding Studies and Personalized Medicine.

Zhao Li1, Sandya R Beeram1, Cong Bi1, D Suresh1, Xiwei Zheng1, David S Hage2.   

Abstract

The binding of drugs with proteins and other agents in serum is of interest in personalized medicine because this process can affect the dosage and action of drugs. The extent of this binding may also vary with a given disease state. These interactions may involve serum proteins, such as human serum albumin or α1-acid glycoprotein, or other agents, such as lipoproteins. High-performance affinity chromatography (HPAC) is a tool that has received increasing interest as a means for studying these interactions. This review discusses the general principles of HPAC and the various approaches that have been used in this technique to examine drug-protein binding and in work related to personalized medicine. These approaches include frontal analysis and zonal elution, as well as peak decay analysis, ultrafast affinity extraction, and chromatographic immunoassays. The operation of each method is described and examples of applications for these techniques are provided. The type of information that can be obtained by these methods is also discussed, as related to the analysis of drug-protein binding and the study of clinical or pharmaceutical samples.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha(1)-acid glycoprotein; Drug–protein binding; Glycation; High-performance affinity chromatography; Human serum albumin; Lipoproteins; Personalized medicine

Mesh:

Substances:

Year:  2015        PMID: 26827600     DOI: 10.1016/bs.apcsb.2015.09.007

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  8 in total

Review 1.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

2.  Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.

Authors:  Sandya R Beeram; Xiwei Zheng; Kyungah Suh; David S Hage
Journal:  Methods       Date:  2018-03-03       Impact factor: 3.608

3.  Optimization of protein entrapment in affinity microcolumns using hydrazide-activated silica and glycogen as a capping agent.

Authors:  John Vargas-Badilla; Saumen Poddar; Shiden Azaria; Chenhua Zhang; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-05-04       Impact factor: 3.205

Review 4.  [Advances in chromatography in the study of drug-plasma protein interactions].

Authors:  Yu Bai; Yufan Fan; Guangbo Ge; Fangjun Wang
Journal:  Se Pu       Date:  2021-10

5.  High-Performance affinity chromatographic studies of repaglinide and nateglinide interactions with normal and glyoxal- or methylglyoxal-modified human albumin serum.

Authors:  Susan T Ovbude; Pingyang Tao; Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2021-04-22       Impact factor: 3.571

6.  Studies of binding by sulfonylureas with glyoxal- and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns.

Authors:  Elliott L Rodriguez; Pingyang Tao; Ashley G Woolfork; Zhao Li; Ryan Matsuda; Zuchen Sun; David S Hage
Journal:  J Chromatogr A       Date:  2020-11-10       Impact factor: 4.759

Review 7.  Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods.

Authors:  Maria Miguel Coelho; Carla Fernandes; Fernando Remião; Maria Elizabeth Tiritan
Journal:  Molecules       Date:  2021-05-23       Impact factor: 4.411

8.  Characterization of drug binding with alpha1-acid glycoprotein in clinical samples using ultrafast affinity extraction.

Authors:  Sandya R Beeram; Chenhua Zhang; Kyungah Suh; William A Clarke; David S Hage
Journal:  J Chromatogr A       Date:  2021-05-11       Impact factor: 4.601

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.